Abetimus
From Wikipedia, the free encyclopedia
Identifiers | |
---|---|
CAS Number | 169147-32-4 ![]() |
ATC code | L04AA22 (WHO) |
ChemSpider | none |
![]() ![]() |
Abetimus is an immunosuppressant.[1] It is a synthetic biological called a tolerogen. It is made of four double-stranded oligodeoxyribonucleotides that are attached to a carrier platform and are designed to block specific B-cell anti double stranded DNA antibodies.[2] It may also complex anti dsDNA antibodies together, therefore disabling them. This way Abetimus is supposed to help treat Systemic Lupus Erythematosus and specifically nephritis.
References[edit]
- ^ (not listed) (2003). "Abetimus: Abetimus sodium, LJP 394". BioDrugs. Adis. 17 (3): 212–215. doi:10.2165/00063030-200317030-00009. ISSN 1173-8804. PMID 12749759.
- ^ Wallace, Daniel J. (January 2001), "Clinical and pharmacological experience with LJP-394", Expert Opinion on Investigational Drugs, Informa, 10 (1), pp. 111–117, doi:10.1517/13543784.10.1.111, ISSN 1354-3784, PMID 11116284, retrieved 2 April 2011
![]() |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |